Wall Street Beat
Weight loss: ReShape Medical forms up $16M | Wall Street Beat
ReShape Medical reeled in $15.8 million of a hoped-for $21.5 million funding round from a group of 7 unnamed investors, according to a regulatory filing.
The San Clemente, Calif.-based medical device company is developing a non-surgical weight loss device, the ReShape Duo, to treat obese patients. The device is a dual balloon designed to take up space in the stomach to reduce its capacity for food.
Volcano claims victory in 1st patent trial against St. Jude Medical
St. Jude sued Volcano in July 2010 in the U.S. District Court for Delaware, accusing it of violating a quintet of patents St. Jude acquired in its 2008 buyout of Radi Medical Systems AB, a Swedish guidewire maker.
Medtech newcomer Sony expands device biz, lays off thousands
There are mass layoffs in the works as electronics giant and medical device industry newcomer Sony Corp. (TYO:6758) continues its company-wide overhaul.
Edwards wins extended Sapien TAVI approval, sinks on disappointing Q3
Edwards Lifesciences (NYSE:EW) won FDA approval to market its Sapien transcatheter aortic valve implantation system to lower-risk patients, despite concerns about limited patient data on the long-term side effects of the device.
Imaging agent maker Shine Medical raises $11M | Wall Street Beat
Shine Medical closed an $11.4 million funding round for its method of generating a low-energy neutron source for medical imaging that uses a particle accelerator instead of a nuclear reactor.
Would Boston Scientific ever sell its coronary stents business?
Fifteen months ago, Cordis Corp. shocked the medical device world by pulling out of the coronary stent game, a business it helped pioneer. I wonder if its possible Boston Scientific (NYSE:BSX) could someday follow their lead.
St. Jude Medical-backed Nanostim drums up $10M | Wall Street Beat
Nanostim, the Sunnyvale, Calif.-based company that’s developing a leadless pacemaker, raised $10 million in an equity and options deal, according to a regulatory filing.
Abbott narrows 2012 guidance, announces more layoffs and tempers M&A outlook
St. Jude Medical slides on potential FDA warning, lowered outlook
St. Jude Medical‘s (NYSE:STJ) stock took a hit today after the medical device company said it might get a warning from the FDA over one of its California factories and lowered its outlook for the rest of the year.
Johnson & Johnson hits 52-week high on boosted earnings forecast | Wall Street Beat
Shares of Johnson & Johnson (NYSE:JNJ) surged to a 52-week high today after the healthcare conglomerate boosted its 2012 earnings forecast after reporting a solid, Street-beating quarter (and despite a nearly 18% bottom-line slide).